363 related articles for article (PubMed ID: 31391345)
1. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.
Ortiz MV; Ahmed S; Burns M; Henssen AG; Hollmann TJ; MacArthur I; Gunasekera S; Gaewsky L; Bradwin G; Ryan J; Letai A; He Y; Naranjo A; Chi YY; LaQuaglia M; Heaton T; Cifani P; Dome JS; Gadd S; Perlman E; Mullen E; Steen H; Kentsis A
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391345
[TBL] [Abstract][Full Text] [Related]
2. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.
Zekri W; Yacoub DM; Ibrahim A; Madney Y
J Egypt Natl Canc Inst; 2020 May; 32(1):21. PubMed ID: 32372372
[TBL] [Abstract][Full Text] [Related]
3. Urinary hyaluronic acid is a Wilms' tumor marker.
Lin RY; Argenta PA; Sullivan KM; Stern R; Adzick NS
J Pediatr Surg; 1995 Feb; 30(2):304-8. PubMed ID: 7738755
[TBL] [Abstract][Full Text] [Related]
4. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
[TBL] [Abstract][Full Text] [Related]
5. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
6. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
7. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
[TBL] [Abstract][Full Text] [Related]
8. Current challenges in Wilms' tumor management.
Gommersall LM; Arya M; Mushtaq I; Duffy P
Nat Clin Pract Oncol; 2005 Jun; 2(6):298-304; quiz 1 p following 324. PubMed ID: 16264987
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Renal Function in Pediatric Patients After Treatment for Wilms' Tumor.
Janeczko M; Niedzielska E; Pietras W
Adv Clin Exp Med; 2015; 24(3):497-504. PubMed ID: 26467140
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
11. [A case of adult Wilms' tumor].
Hosokawa Y; Saiki S; Hanafusa T; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 2001 Sep; 47(9):641-3. PubMed ID: 11692602
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.
Lin RY; Argenta PA; Sullivan KM; Adzick NS
Clin Cancer Res; 1995 Mar; 1(3):327-31. PubMed ID: 9815988
[TBL] [Abstract][Full Text] [Related]
14. Clear cell sarcoma of kidney: A mimicker of Wilms' tumor.
Aviral G; Sarvesh CM; Sushila J; Ansari MS
J Cancer Res Ther; 2023; 19(5):1468-1470. PubMed ID: 37787333
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis and management of Wilms' tumor.
Green DM
Pediatr Clin North Am; 1985 Jun; 32(3):735-54. PubMed ID: 2987781
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center.
Beckwith JB
Hum Pathol; 1983 Jun; 14(6):481-92. PubMed ID: 6303938
[TBL] [Abstract][Full Text] [Related]
17. Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children.
Miniati D; Gay AN; Parks KV; Naik-Mathuria BJ; Hicks J; Nuchtern JG; Cass DL; Olutoye OO
J Pediatr Surg; 2008 Jul; 43(7):1301-7. PubMed ID: 18639686
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study.
Green DM; Breslow NE; Beckwith JB; Takashima J; Kelalis P; D'Angio GJ
J Clin Oncol; 1993 Jan; 11(1):91-5. PubMed ID: 8380295
[TBL] [Abstract][Full Text] [Related]
19. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
Elayadi M; Magdy S; Khalil E; Zekri W
J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204
[TBL] [Abstract][Full Text] [Related]
20. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
